These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17451957)

  • 1. Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype.
    Coman D; McGill J; MacDonald R; Morris D; Klingberg S; Jaeken J; Appleton D
    J Clin Neurosci; 2007 Jul; 14(7):668-72. PubMed ID: 17451957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.
    Aronica E; van Kempen AA; van der Heide M; Poll-The BT; van Slooten HJ; Troost D; Rozemuller-Kwakkel JM
    Acta Neuropathol; 2005 Apr; 109(4):433-42. PubMed ID: 15714316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDG type Ia and congenital cytomegalovirus infection: two coexisting conditions.
    Jamroz E; Adamek D; Paprocka J; Adamowicz M; Marszał E; Wevers RA
    J Child Neurol; 2009 Jan; 24(1):13-8. PubMed ID: 19168813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital disorder of type Ia protein glycosylation: clinical, biochemical and molecular characteristics in 2 siblings with cerebellar hypoplasia].
    Honzík T; Malonová E; Hansíková H; Rosipal R; Poupĕtová H; Martásek P; Zeman J
    Cas Lek Cesk; 2003; 142(5):276-9. PubMed ID: 12920791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PMM2 intronic branch-site mutations in CDG-Ia.
    Vuillaumier-Barrot S; Le Bizec C; De Lonlay P; Madinier-Chappat N; Barnier A; Dupré T; Durand G; Seta N
    Mol Genet Metab; 2006 Apr; 87(4):337-40. PubMed ID: 16376131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
    Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
    Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).
    Schollen E; Kjaergaard S; Legius E; Schwartz M; Matthijs G
    Eur J Hum Genet; 2000 May; 8(5):367-71. PubMed ID: 10854097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations.
    Pérez-Dueñas B; García-Cazorla A; Pineda M; Poo P; Campistol J; Cusí V; Schollen E; Matthijs G; Grunewald S; Briones P; Pérez-Cerdá C; Artuch R; Vilaseca MA
    Eur J Paediatr Neurol; 2009 Sep; 13(5):444-51. PubMed ID: 18948042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conotruncal heart defects in three patients with congenital disorder of glycosylation type Ia (CDG Ia).
    Romano S; Bajolle F; Valayannopoulos V; Lyonnet S; Colomb V; de Baracé C; Vouhe P; Pouard P; Vuillaumier-Barrot S; Dupré T; de Keyzer Y; Sidi D; Seta N; Bonnet D; de Lonlay P
    J Med Genet; 2009 Apr; 46(4):287-8. PubMed ID: 19357119
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate-deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping.
    Vuillaumier-Barrot S; Barnier A; Cuer M; Durand G; Grandchamp B; Seta N
    Hum Mutat; 1999 Dec; 14(6):543-4. PubMed ID: 10571956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia.
    Miossec-Chauvet E; Mikaeloff Y; Heron D; Merzoug V; Cormier-Daire V; de Lonlay P; Matthijs G; Van Hulle C; Ponsot G; Seta N
    Neuropediatrics; 2003 Feb; 34(1):1-6. PubMed ID: 12690561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.
    Schollen E; Kjaergaard S; Martinsson T; Vuillaumier-Barrot S; Dunoe M; Keldermans L; Seta N; Matthijs G
    J Med Genet; 2004 Nov; 41(11):877-80. PubMed ID: 15520415
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbohydrate-deficient glycoprotein syndrome type 1a: a variant phenotype with borderline cognitive dysfunction, cerebellar hypoplasia, and coagulation disturbances.
    van Ommen CH; Peters M; Barth PG; Vreken P; Wanders RJ; Jaeken J
    J Pediatr; 2000 Mar; 136(3):400-3. PubMed ID: 10700701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
    Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
    Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).
    Matthijs G; Schollen E; Bjursell C; Erlandson A; Freeze H; Imtiaz F; Kjaergaard S; Martinsson T; Schwartz M; Seta N; Vuillaumier-Barrot S; Westphal V; Winchester B
    Hum Mutat; 2000 Nov; 16(5):386-94. PubMed ID: 11058895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
    Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
    Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new insight into PMM2 mutations in the French population.
    Le Bizec C; Vuillaumier-Barrot S; Barnier A; Dupré T; Durand G; Seta N
    Hum Mutat; 2005 May; 25(5):504-5. PubMed ID: 15844218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).
    Matthijs G; Schollen E; Pardon E; Veiga-Da-Cunha M; Jaeken J; Cassiman JJ; Van Schaftingen E
    Nat Genet; 1997 May; 16(1):88-92. PubMed ID: 9140401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins.
    Enns GM; Steiner RD; Buist N; Cowan C; Leppig KA; McCracken MF; Westphal V; Freeze HH; O'brien JF; Jaeken J; Matthijs G; Behera S; Hudgins L
    J Pediatr; 2002 Nov; 141(5):695-700. PubMed ID: 12410200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.
    Monin ML; Mignot C; De Lonlay P; Héron B; Masurel A; Mathieu-Dramard M; Lenaerts C; Thauvin C; Gérard M; Roze E; Jacquette A; Charles P; de Baracé C; Drouin-Garraud V; Khau Van Kien P; Cormier-Daire V; Mayer M; Ogier H; Brice A; Seta N; Héron D
    Orphanet J Rare Dis; 2014 Dec; 9():207. PubMed ID: 25497157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.